Thanks Davie. Why is there talk about the results in April resulting in a potential bid by BMS if VLA are only presenting trial results with Keytruda??
Is it because there is a belief that any trials involving Yevroy will be sub optimal and Cavatak will he swooped upon by BMS to boosy resultsy?
